Ameritas Investment Partners’s XBiotech XBIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-1,813
Closed -$5.87K 3358
2025
Q1
$5.87K Hold
1,813
﹤0.01% 2941
2024
Q4
$7.16K Hold
1,813
﹤0.01% 2984
2024
Q3
$14K Hold
1,813
﹤0.01% 2809
2024
Q2
$9.32K Buy
+1,813
New +$14K ﹤0.01% 2947
2022
Q2
Sell
-1,143
Closed -$10K 3253
2022
Q1
$10K Hold
1,143
﹤0.01% 2806
2021
Q4
$13K Hold
1,143
﹤0.01% 2828
2021
Q3
$15K Hold
1,143
﹤0.01% 2827
2021
Q2
$19K Hold
1,143
﹤0.01% 2768
2021
Q1
$20K Hold
1,143
﹤0.01% 2567
2020
Q4
$18K Hold
1,143
﹤0.01% 2532
2020
Q3
$22K Hold
1,143
﹤0.01% 2335
2020
Q2
$16K Hold
1,143
﹤0.01% 2479
2020
Q1
$12K Sell
1,143
-331
-22% -$5.39K ﹤0.01% 2460
2019
Q4
$28K Hold
1,474
﹤0.01% 2245
2019
Q3
$15K Hold
1,474
﹤0.01% 2555
2019
Q2
$11K Buy
+1,474
New +$12.8K ﹤0.01% 2776
2018
Q2
Sell
-1,362
Closed -$7K 3066
2018
Q1
$7K Hold
1,362
﹤0.01% 2816
2017
Q4
$5K Hold
1,362
﹤0.01% 2878
2017
Q3
$6K Hold
1,362
﹤0.01% 2901
2017
Q2
$6K Hold
1,362
﹤0.01% 2921
2017
Q1
$22K Buy
+1,362
New +$17.8K ﹤0.01% 2359

Other funds holding XBIT

Ameritas Investment Partners's XBIT Position: Q2 2025 in Review

Ameritas Investment Partners sold out of XBiotech (XBIT) in Q2 2025, closing a stake of 1,813 shares — an estimated $5.87K sold.

Ameritas Investment Partners first reported a position in XBIT in Q1 2017 and held it in 21 quarters. The position peaked at $28K in Q4 2019. 53 funds tracked by Wall St. Rank hold XBIT as of Q2 2025.

  • Ameritas Investment Partners reported no remaining XBiotech position as of Q2 2025 after selling out during the quarter.
  • Ameritas Investment Partners sold 1,813 XBiotech shares in Q2 2025, an estimated $5.87K.
  • Ameritas Investment Partners first reported a position in XBiotech in Q1 2017 and held it in 21 quarters.
  • Ameritas Investment Partners's XBiotech position peaked at $28K in Q4 2019.
  • 53 funds tracked by Wall St. Rank held XBiotech as of Q2 2025.

Based on Ameritas Investment Partners's 13F filing for Q2 2025, filed 12 Aug 2025.